What is the difference between the Wolverine Stack and the Glow Stack?

The Glow Stack is the Wolverine pairing plus GHK-Cu, a copper-peptide complex — three compounds instead of two. KLOW adds KPV as a fourth. If copper-dependent or melanocortin-linked signaling is not part of your research question, the two-compound Wolverine set is the simpler preparation and the cleaner control.

Is the Wolverine Stack FDA-approved?

No. Neither BPC-157 nor TB-500 is an approved drug in the United States, and the Wolverine Stack has not been evaluated by the FDA. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.

Do I need bacteriostatic water to use the Wolverine Stack?

Not for ours. It ships as a pre-mixed solution, so there is no lyophilized powder to reconstitute. Most other US listings of the same pairing are powder and do require reconstitution, which is where preparation variability enters a two-compound vial.

What is the Wolverine Stack?

7 min read · Updated September 2026 · MY PEPTIDES Research Team

Key facts

The Wolverine Stack is a dual-peptide research formulation supplied as a single pre-mixed vial containing BPC-157 (10mg) and TB-500 (10mg), 20mg in total. BPC-157, a synthetic pentadecapeptide, is studied as a probe for peptide-mediated signaling and cellular-response mechanisms; TB-500, a synthetic 17-amino-acid fragment of thymosin beta-4, is investigated for actin dynamics and cytoskeletal organization. Pairing the two in one characterized vial fixes their ratio at 1:1 by mass and removes the variability of preparing two solutions, so researchers can compare signaling and structural responses side by side under one set of conditions. For US laboratories it ships pre-mixed, with a batch-specific Certificate of Analysis, cold-chain, with tracked delivery across the United States next business day, and is priced in US dollars. It is supplied strictly for in-vitro laboratory research — not for human or veterinary use, it carries no therapeutic claims, and it has not been evaluated by the FDA.

The Wolverine Stack is the industry name for a two-peptide research formulation: BPC-157 (10mg) and TB-500 (10mg) in one vial, 20mg in total. In the United States the same pairing is sold under several labels — Wolverine blend, BPC/TB stack, BPC-157 + TB-500 combo — and, like KLOW and GLOW, the name is a convention rather than a trademark. Wherever you see it, it refers to the same two compounds, and what distinguishes one supplier's version from another's is the ratio, the purity and the documentation, not the name. We list it as the Wolverine Stack, supplied pre-mixed rather than as a powder.

Research use only. The Wolverine Stack is supplied strictly for in-vitro laboratory research. It is not for human or veterinary use, it has not been evaluated by the FDA, and this page does not describe dosing, administration or use in people or animals, and makes no therapeutic claims.

What is in the Wolverine Stack

BPC-157 — 10mg. A synthetic pentadecapeptide, fifteen amino acids long, whose sequence is derived from a protein found in gastric juice. In the research literature it is used as a probe for peptide-mediated signaling and cellular-response mechanisms in cultured systems and animal models. The BPC-157 guide covers the compound on its own.
TB-500 — 10mg. A synthetic 17-amino-acid fragment of thymosin beta-4, corresponding to the region of the parent protein that binds actin. It is examined in actin-binding and cytoskeletal-dynamics research. The TB-500 guide has the detail.

20mg total, split evenly. Unlike the four-compound KLOW blend, where one component makes up most of the mass, the Wolverine Stack is a straight 1:1 pairing by weight. That makes it the easiest of the blends to verify against a certificate: two identities, two quantities, one ratio.

Why the two are paired

The research rationale for a two-compound vial is that the components have distinct, largely non-overlapping mechanisms — one is used as a general peptide-signaling probe, the other is studied for cytoskeletal dynamics — so presenting them together supports questions that two separate vials make harder to ask.

The first is combined versus individual activity: whether a system exposed to both compounds responds differently from the sum of the responses to each one alone. The second is experimental control. Two separate preparations mean two reconstitutions, two sets of pipetting error and two opportunities for concentration drift; a single characterized vial with a fixed ratio removes that variance, which is the practical reason blends appear in comparative protocols at all.

The limitation is the mirror image of the benefit. A combined preparation cannot tell you which component produced an observed effect. Blends are useful for asking whether something happens; single compounds are needed to ask why. Serious protocols usually run both, which is why we also supply BPC-157 and TB-500 individually.

Wolverine, Glow and KLOW

The three stack names describe a nested family, and US searches often confuse them:

Wolverine Stack — BPC-157 and TB-500. Two compounds.
Glow Stack — the same two, plus GHK-Cu. Three compounds.
Klow Stack — Glow plus KPV. Four compounds.

If copper-dependent signaling (GHK-Cu) or melanocortin-linked signaling (KPV) is not part of your question, the two-compound set is the simplest preparation and the cleanest control. The Glow Stack guide covers the three-compound version.

What the research on the components actually examines

Searches for the Wolverine Stack return a great many benefit lists. It is worth separating what the primary literature examines from what is claimed downstream, because the distance between the two is substantial.

The published work on both compounds is in-vitro and preclinical — cultured cell lines and animal models. Findings concern signaling pathways, gene expression and cell behavior under defined conditions, and they vary considerably with concentration, exposure time and model system. A 2025 systematic review of the BPC-157 literature (cited below) is a useful map of what has and has not been studied.

Critically, there is very little published research on the two-compound combination itself. The literature covers BPC-157 and TB-500 separately. Claims about what "the Wolverine Stack does" are therefore extrapolations from single-compound studies, not findings about the pairing — and extrapolating from two separate in-vitro results to a combined effect in a living system is not a step the evidence supports. None of this makes the preparation uninteresting as a research tool; it means the research question and the marketing claim are different things.

Reading the certificate for a two-compound vial

A single-compound Certificate of Analysis reports one purity figure for one molecule. A two-component blend should account for each component — identity and the quantity present — rather than reporting one number for the vial. A certificate that says "99% pure" for a 20mg two-peptide preparation without saying what is in it has not told you the thing you needed to know.

Points worth checking on any Wolverine Stack certificate, from any supplier:

Per-component identity, not just a combined mass
The stated ratio, so you can confirm the 10mg/10mg split rather than assume it
A batch reference that matches the vial in front of you
The analytical method — HPLC for purity, and whether identity was confirmed
A date, since peptide material is not indefinitely stable

Recent certificates for the singles sit in our COA library, and the Certificate of Analysis guide explains how to read one.

Why the pre-mixed format matters for a blend

Most Wolverine Stack listings in the US market are lyophilized powder: two compounds freeze-dried into one vial that the laboratory reconstitutes before use. Reconstitution introduces variability at the best of times — solvent choice, pH, how completely the material dissolves — and with two components it introduces it twice, and not necessarily evenly, so an incompletely mixed vial does not deliver the stated ratio.

Our Wolverine Stack ships as a pre-mixed solution prepared under controlled conditions, which removes that step entirely. For a blend this matters more than for a single compound: the ratio is the product, and a ratio that depends on how thoroughly the end user mixed a powder is not a controlled variable. The trade-off is handling: a solution has to stay refrigerated at 2–8°C and travel cold-chain, which is why it ships the way it does. The pre-mixed vs lyophilized guide sets out the comparison in full, and the peptide calculator handles concentration arithmetic if you need to work from the vial.

How the Wolverine Stack ships in the United States

For US laboratories the Wolverine Stack is supplied as a pre-mixed 20mg vial — BPC-157 10mg, TB-500 10mg — with a batch-specific Certificate of Analysis. Every compound is synthesized in our own laboratory rather than imported and repackaged, and US batches are verified in US laboratories before they ship. Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day, priced in US dollars and payable by Visa, Mastercard or Apple Pay. Store refrigerated at 2–8°C on arrival.

The components are also available individually: BPC-157 and TB-500.

What the Wolverine Stack is not

It is not an approved medicine in the United States or anywhere else, has not been evaluated by the FDA, and is not supplied for human or veterinary use.
It is not a branded formulation — the name is an industry convention, so two suppliers' "Wolverine" vials can differ in ratio, purity and format.
It is not a substitute for single-compound work, for the attribution reason above.

Dosing and administration

We do not publish dosing, reconstitution-for-use or administration guidance for the Wolverine Stack. The material is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, so quantity guidance aimed at a person would be inconsistent with what is actually supplied. Experimental concentrations are specific to the model and endpoint and belong in the primary literature.

Frequently asked questions

What is in the Wolverine Stack?: A single research vial containing BPC-157 (10mg) and TB-500 (10mg) — 20mg total, split 1:1 by mass — supplied pre-mixed for in-vitro laboratory research only.
Is the Wolverine Stack the same as buying BPC-157 and TB-500 separately?: Chemically the components are the same compounds. The difference is the preparation: the stack fixes the two at a 1:1 ratio in one characterized vial, which removes the variability of preparing two solutions but also means you cannot attribute an observed effect to one component. Protocols that need attribution run the singles as well, which is why we supply both.
What is the difference between the Wolverine Stack and the Glow Stack?: The Glow Stack is the Wolverine pairing plus GHK-Cu, a copper-peptide complex — three compounds instead of two. KLOW adds KPV as a fourth. If copper-dependent or melanocortin-linked signaling is not part of your research question, the two-compound Wolverine set is the simpler preparation and the cleaner control.
Is the Wolverine Stack FDA-approved?: No. Neither BPC-157 nor TB-500 is an approved drug in the United States, and the Wolverine Stack has not been evaluated by the FDA. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
Do I need bacteriostatic water to use the Wolverine Stack?: Not for ours. It ships as a pre-mixed solution, so there is no lyophilized powder to reconstitute. Most other US listings of the same pairing are powder and do require reconstitution, which is where preparation variability enters a two-compound vial.
How quickly does the Wolverine Stack ship in the US?: Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day. It is priced in US dollars and payable by Visa, Mastercard or Apple Pay.